EUVIMEDEUVIMED entdecken
Crossref

Expanding cardiac substrates in embolic stroke of undetermined source beyond atrial fibrillation

Osman Karaarslan, Macit Kalçık, Mehmet Mustafa Yılmaz, Oğuzhan Çelik, Abdullah Sarıhan, Mehmet Murat Şahin, Mucahit Yetim, Muhammet Cihat Çelik, Lütfü Bekar, Yusuf Karavelioğlu

Brain & Heart · 08.05.2026 · 4 (3) · 026090012

DOI: 10.36922/bh026090012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain & Heart, online erschienen am 08.05.2026. Verfasst von Osman Karaarslan und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Embolic stroke of undetermined source (ESUS) represents a significant proportion of ischemic strokes in which a definite etiology cannot be identified despite comprehensive diagnostic evaluation. Traditionally, occult atrial fibrillation has been considered the primary underlying mechanism; however, emerging evidence suggests that a broader spectrum of cardiac abnormalities may contribute to embolic risk. The concept of atrial cardiopathy has expanded the understanding of thromboembolic stroke beyond overt atrial fibrillation, highlighting the role of structural, functional, and electrophysiological alterations of the left atrium. In addition to atrial pathology, other potential cardiac sources—including left atrial appendage dysfunction, ventricular thrombus, valvular abnormalities, patent foramen ovale, and heart failure—have been implicated in ESUS. Advances in cardiac imaging, prolonged rhythm monitoring, and biomarker assessment have improved the detection of these covert substrates. Despite these developments, optimal strategies for risk stratification and secondary prevention remain uncertain, as recent trials of empiric anticoagulation in ESUS have yielded neutral results. This review summarizes current evidence on diverse cardiac mechanisms underlying ESUS, outlines diagnostic approaches for identifying occult embolic sources, and discusses implications for targeted management. A more individualized evaluation of cardiac substrates may refine therapeutic decisions and improve the prevention of recurrent stroke in this heterogeneous population.

Zitieren

APA

Karaarslan, O., Kalçık, M., Yılmaz, M. M., Çelik, O., Sarıhan, A., Şahin, M. M., Yetim, M., Çelik, M. C., Bekar, L., & Karavelioğlu, Y. (2026). Expanding cardiac substrates in embolic stroke of undetermined source beyond atrial fibrillation. Brain & Heart, 4(3), 026090012. https://doi.org/10.36922/bh026090012

Vancouver

Karaarslan O, Kalçık M, Yılmaz MM, Çelik O, Sarıhan A, Şahin MM, et al. Expanding cardiac substrates in embolic stroke of undetermined source beyond atrial fibrillation. Brain & Heart. 2026;4(3):026090012. doi:10.36922/bh026090012

BibTeX
@article{Karaarslan2026,
  author = {Karaarslan, Osman and Kalçık, Macit and Yılmaz, Mehmet Mustafa and Çelik, Oğuzhan and Sarıhan, Abdullah and Şahin, Mehmet Murat and Yetim, Mucahit and Çelik, Muhammet Cihat and Bekar, Lütfü and Karavelioğlu, Yusuf},
  title = {Expanding cardiac substrates in embolic stroke of undetermined source beyond atrial fibrillation},
  journal = {Brain & Heart},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {026090012},
  doi = {10.36922/bh026090012}
}
Kostenlos starten →